Niagen Bioscience Launches Niagen™ Plus Liquid At-Home Injections to Support Telehealth ExpansionGuruFocus · 2 days ago
Niagen Bioscience Launches Niagen™ Plus Liquid At-Home Injections to Support Telehealth ExpansionBusiness Wire · 2 days ago
Niagen Bioscience Makes Skincare a Permanent Tru Niagen® Category, Launching Dermatologist-Tested Niagen NanoCloud™ as a Core Tru Niagen® ProductBusiness Wire · 4 days ago
Niagen Bioscience to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026GuruFocus · Oct 15, 2026
Niagen Bioscience to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026Business Wire · Oct 15, 2026
Niagen Bioscience (NASDAQ:NAGE) and Beauty Health (NASDAQ:SKIN) Head to Head ReviewDefense World · Oct 12, 2026Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 4, 2026 | $0.01 | $0.01 | Beat |
| May 6, 2026 | $0.06 | $0.07 | Beat |
| Mar 4, 2026 | $0.02 | $0.03 | Beat |
| Nov 4, 2025 | $0.02 | $0.05 | Beat |
| Aug 6, 2025 | $0.02 | $0.04 | Beat |
| May 7, 2025 | $0.02 | $0.04 | Beat |